|
|
|
Jefferson scientists detail key molecular pathway and potential drug targets against cancer, Alzheimer's and Parkinson's diseases
Researchers have described how two similar proteins compete for control of a cell's ability to die at a preset time. Understanding the molecular secrets of apoptosis, or programmed cell suicide, they say, will enable scientists to identify potential drug targets against neurodegenerative and autoimmune diseases, and cancer. NIH/National Institute of Aging Contact:
Steve Benowitz steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
Message posted by: Wouter Kalle
|
|
Variants Associated with Pediatric Allergic Disorder
Mutations in PHF6 Found in T-Cell Leukemia
Genetic Risk Variant for Urinary Bladder Cancer
Antibody Has Therapeutic Effect on Mice with ALS
Regulating P53 Activity in Cancer Cells
Anti-RNA Therapy Counters Breast Cancer Spread
Mitochondrial DNA Diversity
The Power of RNA Sequencing
‘Pro-Ageing' Therapy for Cancer?
Niche Genetics Influence Leukaemia
Molecular Biology: Clinical Promise for RNA Interference
Chemoprevention Cocktail for Colon Cancer
more news ...
|